US
Revvity Sites Globally
Select your location.
*e-commerce not available for this region.
Technical Note
Development of an AlphaLISA assay for detecting weak interactions between lectins and glycans on antibodies
Unlock the power of AlphaLISA™ technology to detect and analyze weak biomolecular interactions critical for therapeutic antibody development.
Our technical note demonstrates how to develop a highly sensitive AlphaLISA assay for detecting weak binding interactions between lectins and glycans on antibodies.
Key Benefits & Applications:
- No-wash format preserves weak interactions (KD > 1 μM), ideal for lectin-glycan binding
- Monitor N-glycosylation patterns that influence antibody effector functions
- Simplified workflow using Protein G AlphaLISA Acceptor beads
- Essential quality control tool for therapeutic antibody development
Download this technical note to enhance your biomolecular interaction studies and therapeutic antibody characterization workflows.
For research use only. Not for use in diagnostic procedures.
Download Resource
Development of an AlphaLISA assay for detecting weak interactions between lectins and glycans on antibodies